USA flag logo/image

An Official Website of the United States Government

Company Information:

Name: 21ST CENTURY THERAPEUTICS, INC.
Address: 52623 SEVEN OAKS DR
SHELBY TOWNSHIP, MI 48316-2990
Located in HUBZone: No
Woman-Owned: No
Minority-Owned: No
URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $341,709.00 2
SBIR Phase II $1,133,678.00 1

Award List:

Novel Small-molecule TNF-a Modulators as Chemoprotective Agents

Award Year / Program / Phase: 2009 / SBIR / Phase I
Agency: HHS
Principal Investigator: Jiajiu Shaw
Award Amount: $154,852.00
Abstract:
DESCRIPTION (provided by applicant): Cisplatin is a widely used cytotoxic agent with therapeutic activity against various tumors, but also with substantial side effects, including nephrotoxicity, hepatotoxicity and myelosuppression. Therefore, a chemoprote ctive agent which reduces the side effects… More

Novel small-molecule TNF-a modulators as chemoprotective agents

Award Year / Program / Phase: 2011 / SBIR / Phase II
Agency: HHS
Principal Investigator: Jiajiu Shaw – 313-870-1741
Award Amount: $1,133,678.00
Abstract:
DESCRIPTION (provided by applicant): Cisplatin is a widely used cytotoxic agent with therapeutic activity against various tumors, but also with substantial side effects, including nephrotoxicity, hepatotoxicity and myelosuppression. Therefore, a chemoprotective agent which reduces the side effects… More

TAS::75 0849::TAS

Award Year / Program / Phase: 2011 / SBIR / Phase I
Agency: HHS
Principal Investigator: Jiajiu Shaw – 313-874-6798
Award Amount: $186,857.00
Abstract:
Radiotherapy can potentially inflict serious damage on healthy normal organs. For example, pneumonitis and fibrosis are two well-recognized adverse effects from lung cancer radiotherapy: Currently, amifostine (Ethyol) is the only approved radioprotector indicated to reduce xerostomia associated with… More